These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27835950)

  • 1. Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease.
    Matsson H; Söderhäll C; Einarsdottir E; Lamontagne M; Gudmundsson S; Backman H; Lindberg A; Rönmark E; Kere J; Sin D; Postma DS; Bossé Y; Lundbäck B; Klar J
    BMC Pulm Med; 2016 Nov; 16(1):146. PubMed ID: 27835950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon sequencing identifies a novel CHRNA3-CHRNA5-CHRNB4 variant that increases the risk for chronic obstructive pulmonary disease.
    Zhao Z; Peng F; Zhou Y; Hu G; He H; He F; Zou W; Zhao Z; Li B; Ran P
    Respirology; 2015 Jul; 20(5):790-8. PubMed ID: 25891420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
    Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
    Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
    Lee SH; Ahn WY; Seweryn M; Sadee W
    BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
    Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P
    Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers.
    Hopkins RJ; Duan F; Gamble GD; Chiles C; Cavadino A; Billings P; Aberle D; Young RP
    Thorax; 2021 Mar; 76(3):272-280. PubMed ID: 33419953
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Korytina GF; Akhmadishina LZ; Viktorova EV; Kochetova OV; Viktorova TV
    Indian J Med Res; 2016 Dec; 144(6):865-876. PubMed ID: 28474623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.
    Saccone NL; Culverhouse RC; Schwantes-An TH; Cannon DS; Chen X; Cichon S; Giegling I; Han S; Han Y; Keskitalo-Vuokko K; Kong X; Landi MT; Ma JZ; Short SE; Stephens SH; Stevens VL; Sun L; Wang Y; Wenzlaff AS; Aggen SH; Breslau N; Broderick P; Chatterjee N; Chen J; Heath AC; Heliövaara M; Hoft NR; Hunter DJ; Jensen MK; Martin NG; Montgomery GW; Niu T; Payne TJ; Peltonen L; Pergadia ML; Rice JP; Sherva R; Spitz MR; Sun J; Wang JC; Weiss RB; Wheeler W; Witt SH; Yang BZ; Caporaso NE; Ehringer MA; Eisen T; Gapstur SM; Gelernter J; Houlston R; Kaprio J; Kendler KS; Kraft P; Leppert MF; Li MD; Madden PA; Nöthen MM; Pillai S; Rietschel M; Rujescu D; Schwartz A; Amos CI; Bierut LJ
    PLoS Genet; 2010 Aug; 6(8):. PubMed ID: 20700436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
    Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
    COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.
    Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J
    Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.
    Barrie ES; Hartmann K; Lee SH; Frater JT; Seweryn M; Wang D; Sadee W
    Hum Mutat; 2017 Jan; 38(1):112-119. PubMed ID: 27758088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.
    Zhou H; Yang J; Li D; Xiao J; Wang B; Wang L; Ma C; Xu S; Ou X; Feng Y
    J Hum Genet; 2012 Nov; 57(11):738-46. PubMed ID: 22914670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Analysis of Single-Breath Dl
    Sakornsakolpat P; McCormack M; Bakke P; Gulsvik A; Make BJ; Crapo JD; Cho MH; Silverman EK
    Am J Respir Cell Mol Biol; 2019 May; 60(5):523-531. PubMed ID: 30694715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
    Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
    Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.
    Kim WJ; Oh YM; Kim TH; Lee JH; Kim EK; Lee JH; Lee SM; Shin TR; Yoon HI; Lim SY; Lee SD
    Respiration; 2013; 86(2):117-22. PubMed ID: 23207642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.
    Wilk JB; Shrine NR; Loehr LR; Zhao JH; Manichaikul A; Lopez LM; Smith AV; Heckbert SR; Smolonska J; Tang W; Loth DW; Curjuric I; Hui J; Cho MH; Latourelle JC; Henry AP; Aldrich M; Bakke P; Beaty TH; Bentley AR; Borecki IB; Brusselle GG; Burkart KM; Chen TH; Couper D; Crapo JD; Davies G; Dupuis J; Franceschini N; Gulsvik A; Hancock DB; Harris TB; Hofman A; Imboden M; James AL; Khaw KT; Lahousse L; Launer LJ; Litonjua A; Liu Y; Lohman KK; Lomas DA; Lumley T; Marciante KD; McArdle WL; Meibohm B; Morrison AC; Musk AW; Myers RH; North KE; Postma DS; Psaty BM; Rich SS; Rivadeneira F; Rochat T; Rotter JI; Soler Artigas M; Starr JM; Uitterlinden AG; Wareham NJ; Wijmenga C; Zanen P; Province MA; Silverman EK; Deary IJ; Palmer LJ; Cassano PA; Gudnason V; Barr RG; Loos RJ; Strachan DP; London SJ; Boezen HM; Probst-Hensch N; Gharib SA; Hall IP; O'Connor GT; Tobin MD; Stricker BH
    Am J Respir Crit Care Med; 2012 Oct; 186(7):622-32. PubMed ID: 22837378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in genetic background of chronic obstructive pulmonary disease (COPD)].
    Teramoto S
    Nihon Rinsho; 2016 May; 74(5):733-42. PubMed ID: 27254938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Genome Sequencing in Severe Chronic Obstructive Pulmonary Disease.
    Prokopenko D; Sakornsakolpat P; Fier HL; Qiao D; Parker MM; McDonald MN; Manichaikul A; Rich SS; Barr RG; Williams CJ; Brantly ML; Lange C; Beaty TH; Crapo JD; Silverman EK; Cho MH
    Am J Respir Cell Mol Biol; 2018 Nov; 59(5):614-622. PubMed ID: 29949718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.